Lipid Based Formulations of Biopharmaceutics Classification System (BCS) Class II Drugs: Strategy, Formulations, Methods and Saturation

1. Driscoll, C. M. O., 2002: Lipid based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci.,15, 405—415.10.1016/S0928-0987(02)00051-9Search in Google Scholar

2. Hulling, Mu., Holm, R., Mullertz, A., 2013: Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm., 453, 215—224.10.1016/j.ijpharm.2013.03.054Search in Google Scholar

3. Humberstone, A. J., Charman, W. N., 1995: Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev., 25, 103—128.10.1016/S0169-409X(96)00494-2Search in Google Scholar

4. Charman, W. N., Porter, C. J., Mithani, S., Dressman, J. B., 1997: Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci., 86, 269—282.10.1021/js960085vSearch in Google Scholar

5. Kalepu, S., Manthina, M., Padavala, V., 2013: Oral lipid-based drug delivery systems — an overview. Acta Pharmaceutica Sinica B, 3, 361—372.10.1016/j.apsb.2013.10.001Search in Google Scholar

6. Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., 2011: Formulation design of poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int. J. Pharm., 420, 1—10.10.1016/j.ijpharm.2011.08.032Search in Google Scholar

7. Osterberg, R. E., See, N. A., 2003: Toxicity of excipients — a food and drug administration perspective. Int. J. Toxicol., 22, 37—380.10.1177/109158180302200507Search in Google Scholar

8. Pouton, C. W., Porter, Ch. J. H., 2008: Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv. Drug Deliv. Rev., 60, 625—637.10.1016/j.addr.2007.10.010Search in Google Scholar

9. Porter, C. J., Charman, W. N., 2001: In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev., 50, 127—147.10.1016/S0169-409X(01)00182-XSearch in Google Scholar

10. Porter, C. J., Treyaskis, N. L., Charman, W. N., 2007: Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Discovery, 6, 231—248.10.1038/nrd219717330072Search in Google Scholar

11. Pramod, K., Peeyush, K., Rajeev, K., Nitish, K., Rakesh, K., 2010: An overview of lipid based formulation for oral drug delivery. Drug Inv. Today, 2, 390—395.Search in Google Scholar

12. The United States Pharmacopoeia Convention (2009) [online]. United States Pharmacopoeia excipient verification program. 35—40. http://www.usp.org/sites/default/files/usp_pdf/EN/products/usp2008p2supplement3.pdfSearch in Google Scholar

13. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E. Jr., Walle, U. K., 2004: High absorbtion but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos., 32, 1337—1382.10.1124/dmd.104.00088515333514Search in Google Scholar

14. Wilson, C. G., Mahony, B. O., 1997: The behaviour of fats and oils in the upper G. I. Tract. Bulletin Technique Gattefosse, 90, 13−18.Search in Google Scholar